Table 3.

Between administration-time differences (ANOVA).

Clinical Scale
Dimension	F	p	ηp2	Multiple Comparisons	Mean Difference	Std. Error	Sig.
MMSE	1.56	0.234	0.107	T1 vs. T2
BPRS	0.296	0.596	0.022	T1 vs. T2
K_Axis	3.157	0.008	0.195	T1 vs. T2
PI				T1 vs. T2	1.25	1.821	-
SS				T1 vs. T2	3.194	3.051	-
Vi				T1 vs. T2	−13.333	5.090	0.05 *
OI				T1 vs. T2	−5.556	0.021	-
SA				T1 vs. T2	−4.861	0.265	0.05 *
CPC				T1 vs. T2	−7.917	0.004	0.01 **
AI				T1 vs. T2	0.000	1.00	-
GAF Eq.	4.316	0.058	0.249	T1 vs. T2
GAF K	0.671	0.428	0.049	T1 vs. T2
DL	0.985	0.339	0.070	T1 vs. T2

* p < 0.05. ** p < 0.01; K_Axis = Kennedy Axis V; PI = Psychological impairment; SS = Social skills; Vi = Violence; OI = ADL-Occupational Skills; SA = Substance abuse; CPC = Compromising of physical conditions: Medical impairment; AI = Ancillary impairment; GAF Eq = Global Evaluation Functioning Equivalent, a score that provides an average and global representation of the patient’s functioning. It is obtained from the average of the first four Kennedy Axis V scales; GAF K = Global assessment of functioning. Global functioning obtained by selecting the lowest of the scores from the first four areas; DL = Danger level, this index identifies the highest risk score among those obtained in the seven areas.